CDK6 and malignant glioma: Immunoblotting confirmed increased CDK6 protein expression in malignant gliomas consistent with the elevated transcript levels (Figure 1f), and immunohistochemistry verified the graded distribution of the protein in the tumors (Figure 1a–d).